[Clinical study of analgesic effect of lornoxicam in nasal packing].
OBJECTIVE
To explore the pain control effect of lornoxicam on patients after nasal packing.


METHODS
A total of 56 patients undergoing nasal packing between January 2011 and August 2011 were randomly divided into the treatment group and control group. (1) Treatment group: routinely given lornoxicam for injection 8 mg(2 ml), intravenous injection, twice a day; (2) CONTROL GROUP: given saline 2 ml, intravenous injection, twice a day, other treatments are the same with the treatment group. Visual analog scale was used to record the painful severity of nose and head at 3, 6, 12, 24 and 48 h,and record the sleep quality score at 24 and 48 h.


RESULTS
The pain in nose and head and night sleeping in treatment group were all significantly better than that in control group.


CONCLUSIONS
The analgesic effect of lornoxicam in nasal packing is good, with no evident adverse reactions.
Department of Otorhinolaryngology, People's Hospital of Yuyao, Yuyao 315400, China. wgluzhonghua@sina.com
Zhonghua
Z
Lu
Department of Otorhinolaryngology, People's Hospital of Yuyao, Yuyao 315400, China.
Qi
Q
Zhu
Department of Otorhinolaryngology, People's Hospital of Yuyao, Yuyao 315400, China.
Jianmiao
J
Fang
Department of Otorhinolaryngology, People's Hospital of Yuyao, Yuyao 315400, China.
Guanghua
G
Peng
Department of Otorhinolaryngology, People's Hospital of Yuyao, Yuyao 315400, China.
Suzhen
S
Xu
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity / Q000601:surgery; D059747:Nasal Surgical Procedures / Q000009:adverse effects; D010149:Postoperative Pain / Q000188:drug therapy*; D010894:Piroxicam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
D000700:Analgesics; D010894:Piroxicam; C059451:lornoxicam